EBMT 2016 Highlights: Expert discussion

Novel technologies for understanding the repertoire of tumour infiltrating T cells in cancer

Targeting AFP in hepatocellular cancer

How singing in a choir may help boost immune systems of cancer patients

Combination of viroimmunotherapy with checkpoint inhibitors

Is PD-L1 really a predictive biomarker?

Patient perspective on immunotherapy and the ITOC-3 conference

Hypoxia and its impact on the immune system

The role of microRNAs in modulation of the immune escape of tumors

Reprogramming the cancer microenvironment with vaccine-based therapy

T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy

Biomarkers in t-cell therapy trials